Exjade and Eczema - a phase IV clinical study of FDA data

Summary:

Eczema is reported as a side effect among people who take Exjade (deferasirox), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Desferal, and have Myelodysplastic syndrome.

The phase IV clinical study analyzes which people have Eczema when taking Exjade. It is created by eHealthMe based on reports of 29,418 people who have side effects when taking Exjade from the FDA, and is updated regularly.

What is Exjade?

Exjade has active ingredients of deferasirox. It is often used in iron overload. eHealthMe is studying from 29,456 Exjade users. Check the latest studies of Exjade.

What is Eczema?

Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters) is found to be associated with 1,488 drugs and 1,944 conditions by eHealthMe. Check the latest studies of Eczema.

On Jul, 17, 2026

29,418 people reported to have side effects when taking Exjade.
Among them, 38 people (0.13%) have Eczema.

Among these 38 people:

How long have people been on Exjade when they have Eczema? *

What is the gender of people who have Eczema when taking Exjade? *

female: 52.63 %
male: 47.37 %

What is the age of people who have Eczema when taking Exjade? *

What are other drugs people take besides Exjade? *

What are other side effects people have besides Eczema? *

Rashes (redness): 15 people, 39.47%
Urticaria (rash of round, red welts on the skin that itch intensely): 11 people, 28.95%
Fever: 9 people, 23.68%
Serum Ferritin Increased: 8 people, 21.05%
Diarrhea: 7 people, 18.42%
Itching: 7 people, 18.42%
Nausea (feeling of having an urge to vomit): 6 people, 15.79%
Hip Fracture: 4 people, 10.53%
Rash Pruritic (redness with itching): 4 people, 10.53%
Renal Impairment (severely reduced kidney function): 4 people, 10.53%

What are the existing conditions these people have? *

Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 16 people, 42.11%
Cough: 2 people, 5.26%
Gastritis (inflammation of stomach): 2 people, 5.26%
Haemosiderosis (general increase in tissue iron stores without associated tissue damage): 2 people, 5.26%
Joint Pain: 1 person, 2.63%
Cerebrovascular Disorder (disease of brain): 1 person, 2.63%
Constipation: 1 person, 2.63%
Haemochromatosis (body to absorb more iron than usual from food): 1 person, 2.63%
Wheezing (a high-pitched whistling sound made while you breath): 1 person, 2.63%
Venipuncture: 1 person, 2.63%

* Approximation only. Some reports may have incomplete information.

Do you take Exjade and have Eczema?

- Check whether Eczema is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Exjade:

Exjade (29,456 reports)

Eczema treatments and more:

Eczema (61,311 reports)

Browse all side effects of Exjade:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Eczema:

Eczema (1,488 drugs)

Browse all the conditions that are associated with Eczema:

Eczema (1,944 conditions)

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on deferasirox (the active ingredients of Exjade) and Exjade (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.